Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 61 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
PHARMIDABLE from Namur, company number BE1009825725, closed financial year 2024 with a result of € -28,258 after tax. For that financial year PHARMIDABLE recorded a gross margin of € -6,385 and equity of € 31,742. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 3, 2025.
€ 31,742
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -28,258
Profit after tax over the fiscal year.
€ 37,345
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -28,258.
People and assets in 2024
€ 4,129
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,996
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 640,875
€ 143,439 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 93,467
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to PHARMIDABLE?
What happened at PHARMIDABLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Florence Dandois stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 28,258. filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
- Florence Dandois became a director. NBB
A new publication or filing at PHARMIDABLE? We notify you, reason included.
Follow PHARMIDABLEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Florence Dandois
Director
since 2024 · until 2026
Establishments
Establishment units
Physical locations of this company
Rue de Mosanville(LI) 42
5101 Namur
Rue de la Broucheterre 18
6000 Charleroi
Active since 29 May 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1009.825.725
- VAT number
- BE 1009.825.725
- Registered office
- Rue de Mosanville(LI) 42, 5101 Namur
- Names & denominations
- PHARMIDABLE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 May 2024
- Peppol
- Active · Active since 10 Sept 2026
- Activities · NACE
Detailhandel in farmaceutische producten